{
    "id": "9cecd2e2-7a8d-44a7-8025-d9d8a76531ad",
    "indications": {
        "text": "relief symptoms depression . endogenous depression likely alleviated depressive states . one three weeks treatment may needed optimal therapeutic effects evident .",
        "doid_entities": [
            {
                "text": "depression (DOID:1596)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1596"
            },
            {
                "text": "endogenous depression (DOID:1595)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1595"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "following recommended dosages imipramine pamoate capsules modified necessary response evidence intolerance .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "imipramine pamoate capsules usp 75 mg size `` 2 `` capsule brown cap brown body , imprinted `` lu `` black ink cap `` u01 `` black ink body , containing pale yellow yellow granular powder . supplied follows : ndc 68180-314-06 bottles 30 's imipramine pamoate capsules usp 100 mg size `` 1 `` capsule brown cap dark yellow body , imprinted `` lu `` black ink cap `` u02 `` black ink body , containing pale yellow yellow granular powder . supplied follows : ndc 68180-315-06 bottles 30 's imipramine pamoate capsules usp 125 mg size `` 1 `` capsule brown cap light yellow body , imprinted `` lu `` black ink cap `` u03 `` black ink body , containing pale yellow yellow granular powder . supplied follows : ndc 68180-316-06 bottles 30 's imipramine pamoate capsules usp 150 mg size `` 0 `` capsule brown cap brown body , imprinted `` lu `` black ink cap `` u04 `` black ink body , containing pale yellow yellow granular powder . supplied follows : ndc 68180-317-06 bottles 30 's store 20\u00b0c 25\u00b0c ( 68\u00b0 77\u00b0f ) [ usp controlled room temperature ] . dispense tight container ( usp ) child-resistant closure .",
    "ingredients": [
        {
            "name": "IMIPRAMINE PAMOATE",
            "code": "MC34P30298",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_47499"
        },
        {
            "name": "FD&C BLUE NO. 1",
            "code": "H3R47K3TBD"
        },
        {
            "name": "FD&C RED NO. 40",
            "code": "WZB9127XOA"
        },
        {
            "name": "FD&C YELLOW NO. 6",
            "code": "H77VEI93A8"
        },
        {
            "name": "GELATIN",
            "code": "2G86QN327L",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_5291"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_16189"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32178"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        },
        {
            "name": "D&C YELLOW NO. 10",
            "code": "35SW5USQ3G"
        }
    ],
    "organization": "Lupin Pharmaceuticals, Inc.",
    "name": "Imipramine Pamoate",
    "effectiveTime": "20250121",
    "indications_original": "For the relief of symptoms of depression. Endogenous depression is more likely to be alleviated than other depressive states. One to three weeks of treatment may be needed before optimal therapeutic effects are evident.",
    "contraindications_original": "The following recommended dosages for imipramine pamoate capsules should be modified as necessary by the clinical response and any evidence of intolerance.",
    "warningsAndPrecautions_original": "Imipramine Pamoate Capsules USP 75 mg are size \"2\" capsule with brown cap and brown body, imprinted with \"LU\" in black ink on cap and \"U01\" in black ink on body, containing pale yellow to yellow granular powder.\n                  They are supplied as follows:\n                  NDC 68180-314-06\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Bottles of 30's\n                  Imipramine Pamoate Capsules USP 100 mg are size \"1\" capsule with brown cap and dark yellow body, imprinted with \"LU\" in black ink on cap and \"U02\" in black ink on body, containing pale yellow to yellow granular powder.\n                  They are supplied as follows:\n                  NDC 68180-315-06\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Bottles of 30's\n                  Imipramine Pamoate Capsules USP 125 mg are size \"1\" capsule with brown cap and light yellow body, imprinted with \"LU\" in black ink on cap and \"U03\" in black ink on body, containing pale yellow to yellow granular powder.\n                  They are supplied as follows:\n                  NDC 68180-316-06\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Bottles of 30's\n                  Imipramine Pamoate Capsules USP 150 mg are size \"0\" capsule with brown cap and brown body, imprinted with \"LU\" in black ink on cap and \"U04\" in black ink on body, containing pale yellow to yellow granular powder.\n                  They are supplied as follows:\n                  NDC 68180-317-06\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Bottles of 30's\n                  Store at 20\u00b0C to 25\u00b0C (68\u00b0 to 77\u00b0F) [see USP Controlled Room Temperature]. \n                  Dispense in tight container (USP) with a child-resistant closure.",
    "drug": [
        {
            "name": "Imipramine Pamoate",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_47499"
        }
    ]
}